See All Slides -

Slides

Presentation TCT 2021

Acute and Long-term Improvements Following FlowTriever Mechanical Thrombectomy in Pulmonary Embolism Patients: Six-Month Results From the FLASH Registry

Presenter: Catalin Toma

November 06, 2021

Presentation TCT 2021

What Is the Definition and Clinical Impact of Prosthesis-Patient Mismatch in TAVR

Presenter: Philippe Pibarot

November 06, 2021

Presentation TCT 2021

Post-PCI Phase (Patient in NSR): Long-term Prevention of Bleeding

Presenter: Davide Capodanno

November 06, 2021

Presentation TCT 2021

Case #1 Resolution: A Patient With High Bleeding and High Ischemic Risk

Presenter: Davide Cao

November 06, 2021

Presentation TCT 2021

IVUS Consensus Document Results

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

TRISCEND: Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation

Presenter: Susheel Kodali

November 06, 2021

Presentation TCT 2021

Case #1 Introduction: A Patient With High Bleeding and High Ischemic Risk

Presenter: Davide Cao

November 06, 2021

Presentation TCT 2021

Changes in Voice Patterns for Monitoring Volume Status (Cardio)

Presenter: Chaim Lotan

November 06, 2021

Presentation TCT 2021

Inferior Vena Caval Size Monitoring

Presenter: Jeffrey Testani

November 06, 2021

Presentation TCT 2021

Intrepid TMVR Early Feasibility: Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement

Presenter: Firas Zahr

November 06, 2021

Advertisement

Slides

Acute and Long-term Improvements Following FlowTriever Mechanical Thrombectomy in Pulmonary Embolism Patients: Six-Month Results From the FLASH Registry

What Is the Definition and Clinical Impact of Prosthesis-Patient Mismatch in TAVR

Post-PCI Phase (Patient in NSR): Long-term Prevention of Bleeding

Case #1 Resolution: A Patient With High Bleeding and High Ischemic Risk

IVUS Consensus Document Results

TRISCEND: Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation

Case #1 Introduction: A Patient With High Bleeding and High Ischemic Risk

Changes in Voice Patterns for Monitoring Volume Status (Cardio)

Inferior Vena Caval Size Monitoring

Intrepid TMVR Early Feasibility: Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content